ZEALAND PHARMA A/S

CVR 20045078 · Public limited company (A/S) · Active · Low risk

ZEALAND PHARMA A/S is a Public limited company (A/S), founded on , based in Søborg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 20 annual reports have been published. CEO: Henriette Wennicke.

Bankruptcy risk for ZEALAND PHARMA A/S

0.4%
probability of bankruptcy within 12 months
Low risk

0.3 × the average (1.41%) · higher risk than 58% of active Danish companies

Lowest riskHighest risk

Increases the risk

Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×

Reduces the risk

Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Employees (latest year)100+ · bankruptcy rate 2.3%0.27×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Reporting classReporting class D · bankruptcy rate 3.9%0.44×
Company typeA/S · bankruptcy rate 4.4%0.50×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
20045078
Status
Active
Company type
Public limited company (A/S)
Founded
(29 years)
Address
Sydmarken 11
2860 Søborg
Municipality
Gladsaxe
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 71.6m
Employees
153 (2018)
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late1 of 28
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total16
CEO's previous bankruptcies0
Other companies at the address3
Going-concern uncertaintyNo

Financials and key figures

Financial year2026202520252024

Latest annual report: Reporting class D · auditor's statement: No audit assistance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202586
1 Jan 2024 – 31 Dec 202494
1 Jan 2023 – 31 Dec 202381
1 Jan 2022 – 31 Dec 202293
1 Jan 2021 – 31 Dec 2021124
1 Jan 2020 – 31 Dec 2020111
1 Jan 2019 – 31 Dec 201999
1 Jan 2018 – 31 Dec 2018119
1 Jan 2017 – 31 Dec 2017110
1 Jan 2016 – 31 Dec 2016101
1 Jan 2015 – 31 Dec 2015117
1 Jan 2014 – 31 Dec 2014116
1 Jan 2013 – 31 Dec 2013168
1 Jan 2012 – 31 Dec 2012141
1 Jan 2011 – 31 Dec 2011120
1 Jan 2010 – 31 Dec 2010125
1 Jan 2009 – 31 Dec 2009125
1 Jan 2008 – 31 Dec 2008124
1 Jan 2007 – 31 Dec 2007175
1 Jan 2006 – 31 Dec 2006112

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOHenriette WennickeCurrent
CEOPer Emil Hasselbalch Stakemann
CEOJørgen Søberg Petersen
CEOMogens Ibenfeldt
CEOChristian Grøndahl
CEOJohn Hyttel
CEOMats Blom
CEOAdam Sinding Steensberg
CEOMatthew Donald Dallas
BoardAlf Gunnar Martin NicklassonCurrent
BoardKirsten Aarup DrejerCurrent
BoardLeonard KruimerCurrent
BoardAnneline NansenCurrent
BoardLudovic Tranholm OtterbeinCurrent
BoardNikolaj Frederik BeckCurrent
BoardAdam Krisko NygaardCurrent
BoardTanja Lund ErichsenCurrent
BoardKatja Haaber Løje HansenCurrent
BoardLars Elmelund PedersenCurrent
BoardCecilie KoldCurrent
BoardElaine SullivanCurrent
BoardEnrique Alfredo Conterno MartinelliCurrent
BoardIris Katharina Löw-FriedrichCurrent
BoardCamilla SylvestCurrent
BoardDan Buxbom
BoardLeif Helth Jensen
BoardNiels Erik Nielsen
BoardJørgen Buus Lassen
BoardLeif Helth Jensen
BoardLeslie Lars Iversen
BoardMichael Thomas Sember
BoardBent Benny Andersen
BoardTom Larsen
BoardGudmund Tyge Korsgaard
BoardPatrick John Paul Coleman
BoardBo Lennart Bruce
BoardKetil Jørgen Haugan
BoardJan Honoré
BoardLone Skjøttgaard Due
BoardThierry Claude Laugel
BoardLars Kolind
BoardDr Alain Munoz
BoardChristian Thorkildsen
BoardChristian Thorkildsen
BoardJean Christophe Renondin
BoardRémi Droller
BoardMarlene Nørgaard Carolus
BoardJesper Zeuthen
BoardAlain Munoz
BoardLinda Sjøstrøm
BoardJens William Kindtler
BoardChristian Herskind Jørgensen
BoardHelle Størum
BoardHelle Størum
BoardThomas Tscherning
BoardAnders Vadsholt
BoardFlorian Nicolas Christian Reinaud
BoardJutta Grevinde af Rosenborg
BoardJames Peter Arthur Benson
BoardHanne Heidenheim Bak
BoardMichael John Owen
BoardJørgen Lindegaard
BoardDaniël Jan Ellens
BoardSøren Vitfell Keller
BoardHanne Heidenheim Bak
BoardJens Peter Stenvang
BoardMaria Juul Kolding
BoardRosemary Crane
BoardCatherine Moukheibir
BoardAnne Kragh Sager
BoardAnneline Nansen
BoardHanne Heidenheim Bak
BoardHelle Haxgart
BoardHelle Størum
BoardChristian Thorkildsen
BoardRasmus Just
BoardHelle Haxgart
BoardKirsten Aarup Drejer
BoardJeffrey Berkowitz
BoardBernadette Mary Connaughton
BoardGertrud Koefoed Rasmussen
BoardJacob Ulrik Fog
BoardNikolaj Frederik Beck
BoardIben Louise Gjelstrup
Owner (5%)Polar Capital LLPCurrent
Owner (5%)Avoro Life Sciences Fund LLCCurrent
Owner (0%)Avoro Capital Advisors LLCCurrent
Owner (5%)Van Herk Investments B.V.Current
Owner (0%)Van Herk Management Services B.V.Current
Owner (5%)ZEALAND PHARMA A/SCurrent
Owner (10%)Innovation Capital
Owner (0%)Innovation Capital
Owner (5%)CDC Enterprises Capital Investissement
Owner (5%)CDC Enterprises Capital Investissement
Owner (0%)SUNSTONE CAPITAL A/S
Owner (5%)SUNSTONE LIFE SCIENCE VENTURES FUND I K/S
Owner (5%)K/S SUNSTONE BIOMEDICAL VENTURE ANNEX III
Owner (10%)KAPITALFORENINGEN LD
Owner (5%)CDC Enterprises Capital Investissement
Owner (0%)Legg Mason, Inc.
Owner (0%)SUNSTONE CAPITAL A/S
Owner (5%)KAPITALFORENINGEN LD
Owner (0%)SUNSTONE LIFE SCIENCE VENTURES A/S
Owner (0%)SUNSTONE LIFE SCIENCE VENTURES A/S
Owner (5%)Wellington Management Group LLP
Owner (15%)Van Herk Investments B.V.
Owner (0%)Van Herk Management Services B.V.
Owner (0%)Wellington Management Group LLP
Owner (5%)Wellington Management Group LLP
Owner (10%)Van Herk Investments B.V.
Owner (0%)Van Herk Management Services B.V.
Owner (10%)Polar Capital LLP
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorERNST & YOUNG DENMARK P/S
AuditorH.E.H. 4 A/S
AuditorDELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorGreen IV ApS
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
AuditorEY Godkendt Revisionspartnerselskab
FounderVX 10.312 ApSCurrent

The CEOs' other companies

Henriette Wennicke – 3 other companies

Per Emil Hasselbalch Stakemann – 45 other companies, of which 45 bankrupt

Jørgen Søberg Petersen – 10 other companies

Mogens Ibenfeldt – 3 other companies

Christian Grøndahl – 9 other companies

John Hyttel – 1 other companies

Adam Sinding Steensberg – 8 other companies

Address history (2 moves)

Sydmarken 11, 2860 Søborg
Smedeland 36, 2600 Glostrup
Smedeland 26B, 2600 Glostrup

Former names

ZEALAND PHARMA A/S – now
ZEALAND PHARMACEUTICALS A/S –
PEPTIDE PROBE TECHNOLOGIES ApS –
ApS KBUS 8 NR. 4581 –

Employees per year

Number of employees at ZEALAND PHARMA A/S per year771532011: 9020112012: 9320122013: 10620132014: 10320142015: 11720152016: 13320162017: 13320172018: 1532018

Other companies at the same address

Similar companies in Gladsaxe

Questions and answers about ZEALAND PHARMA A/S

Has ZEALAND PHARMA A/S gone bankrupt?

No, ZEALAND PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of ZEALAND PHARMA A/S?

Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.

Who is the CEO of ZEALAND PHARMA A/S?

Henriette Wennicke is the CEO of ZEALAND PHARMA A/S.

Who is the auditor of ZEALAND PHARMA A/S?

ZEALAND PHARMA A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was ZEALAND PHARMA A/S founded?

ZEALAND PHARMA A/S was founded on 1 April 1997.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.